These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38449096)

  • 21. Cumulative cancer incidence and mortality after kidney transplantation in Japan: A long-term multicenter cohort study.
    Imamura R; Nakazawa S; Yamanaka K; Kakuta Y; Tsutahara K; Taniguchi A; Kawamura M; Kato T; Abe T; Uemura M; Takao T; Kishikawa H; Nonomura N
    Cancer Med; 2021 Apr; 10(7):2205-2215. PubMed ID: 33314709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alemtuzumab Induction Is Associated With Equalization of Graft Outcomes Between Elderly and Nonelderly Kidney Transplant Recipients: A Single-Center Report.
    DeLeonibus A; Mitro G; Brooks J; Rees M; Ortiz J
    Exp Clin Transplant; 2020 Jun; 18(3):284-291. PubMed ID: 31050614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT.
    Florman S; Vincenti F; Durrbach A; Abouljoud M; Bresnahan B; Garcia VD; Mulloy L; Rice K; Rostaing L; Zayas C; Calderon K; Meier-Kriesche U; Polinsky M; Yang L; Medina Pestana J; Larsen CP
    Clin Transplant; 2018 Apr; 32(4):e13225. PubMed ID: 29461660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes.
    Gerbase-DeLima M; de Marco R; Monteiro F; Tedesco-Silva H; Medina-Pestana JO; Mine KL
    Front Immunol; 2020; 11():954. PubMed ID: 32528472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
    Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of renal function on long-term graft survival and patient survival in renal transplant recipients.
    Smith-Palmer J; Kalsekar A; Valentine W
    Curr Med Res Opin; 2014 Feb; 30(2):235-42. PubMed ID: 24128389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
    Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
    Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion from Calcineurin Inhibitor- to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial.
    Budde K; Prashar R; Haller H; Rial MC; Kamar N; Agarwal A; de Fijter JW; Rostaing L; Berger SP; Djamali A; Leca N; Allamassey L; Gao S; Polinsky M; Vincenti F
    J Am Soc Nephrol; 2021 Dec; 32(12):3252-3264. PubMed ID: 34706967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recipient-related risk factors for graft failure and death in elderly kidney transplant recipients.
    Lai X; Chen G; Qiu J; Wang C; Chen L
    PLoS One; 2014; 9(11):e112938. PubMed ID: 25389964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is COVID-19 infection more severe in kidney transplant recipients?
    Caillard S; Chavarot N; Francois H; Matignon M; Greze C; Kamar N; Gatault P; Thaunat O; Legris T; Frimat L; Westeel PF; Goutaudier V; Jdidou M; Snanoudj R; Colosio C; Sicard A; Bertrand D; Mousson C; Bamoulid J; Masset C; Thierry A; Couzi L; Chemouny JM; Duveau A; Moal V; Blancho G; Grimbert P; Durrbach A; Moulin B; Anglicheau D; Ruch Y; Kaeuffer C; Benotmane I; Solis M; LeMeur Y; Hazzan M; Danion F;
    Am J Transplant; 2021 Mar; 21(3):1295-1303. PubMed ID: 33259686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients.
    Sethi S; Najjar R; Peng A; Choi J; Lim K; Vo A; Jordan SC; Huang E
    Transplantation; 2020 Jul; 104(7):1500-1507. PubMed ID: 31568398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospitalized avascular necrosis after renal transplantation in the United States.
    Abbott KC; Oglesby RJ; Agodoa LY
    Kidney Int; 2002 Dec; 62(6):2250-6. PubMed ID: 12427153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Single-Center Assessment of Delayed Graft Function in Recipients of Simultaneous Liver and Kidney Transplant.
    Aziz F; Gardezi A; Muth B; Blazel J; Garg N; Mohammed M; Mezrich J; Djamali A; Mandelbrot D; Parajuli S
    Prog Transplant; 2020 Dec; 30(4):342-348. PubMed ID: 32930044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avascular necrosis of bone following renal transplantation.
    Naiker IP; Govender S; Naicker S; Dawood S; Haffejee AA; Seedat YK
    S Afr Med J; 1993 Sep; 83(9):646-9. PubMed ID: 8310355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
    Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
    Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Kidney Transplant Center Volume With 3-Year Clinical Outcomes.
    Sonnenberg EM; Cohen JB; Hsu JY; Potluri VS; Levine MH; Abt PL; Reese PP
    Am J Kidney Dis; 2019 Oct; 74(4):441-451. PubMed ID: 31076173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney transplant outcomes among recipients with post-transplant hip or knee joint replacement surgery.
    Dodin B; Breyer I; Osman F; Alstott J; Aziz F; Garg N; Mohamed M; Mandelbrot D; Djamali A; Parajuli S
    Clin Transplant; 2022 Apr; 36(4):e14564. PubMed ID: 34936127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.
    Luan FL; Schaubel DE; Zhang H; Jia X; Pelletier SJ; Port FK; Magee JC; Sung RS
    Transplantation; 2008 Jun; 85(11):1601-6. PubMed ID: 18551066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.
    Lam NN; Garg AX; Knoll GA; Kim SJ; Lentine KL; McArthur E; Naylor KL; Bota SE; Sood MM
    Am J Nephrol; 2017; 46(4):343-354. PubMed ID: 29024935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.